Features

IAS 2017: Progress on PrEP, treatment as prevention, and HIV cure science

While the world’s top HIV experts reported no earth shattering progress in preventing, treating or curing HIV at the 9th IAS Conference on HIV Science (IAS 2017), which took place in July in Paris, it did serve as an important marker of progress. HIV researchers revealed new data that further strengthened the case for PrEP(…)

Planned Parenthood and Black AIDS Institute Announces Program to Expand HIV Services

 Planned Parenthood has announced a multi-phase pilot program to build and expand its comprehensive HIV prevention and education efforts. Gilead Sciences, Inc, a research-based biopharmaceutical company, awarded the $900,000 grant to support and expand efforts of HIV prevention and education, including the integration of Pre-Exposure Prophylaxis (PrEP) awareness, at Planned Parenthood affiliate health centers across(…)

‘Billion Dollar Roundtable’ Now Includes LGBT, Nisability and Veteran-owned Businesses

The National Gay & Lesbian Chamber of Commerce (NGLCC), the business voice of the LGBT community, and the USBLN (US Business Leadership Network), the disability inclusion business resource, have announced that The Billion Dollar Roundtable has voted to expand their criteria of diverse businesses counted toward a corporation’s billion dollar supply chain spend on diverse-owned(…)

NMAC Launches Campaign to Fight Proposed Cuts to HIV Services

Today, NMAC Launches “Save Our Services,” an innovative campaign created to empower Americans across the country in fighting the proposed federal budget cuts that would cause severe harm to vital HIV treatment and prevention services. SOS will enlist the advocacy of community volunteers to contact their representatives in Congress both in their home offices during(…)

Clinical Laboratories Key to Breaking Down the Health Care Barriers Faced by Trans Patients

Clinical laboratories could significantly improve healthcare for the transgender community by using both sex and gender identity to make decisions about clinical testing, and by determining normal lab values for healthy transgender patients. A review published today in AACC’s Clinical Chemistry journal emphasizes these as critical steps on the road to eliminating the many hurdles that(…)